Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: A therapeutic benefit for arthritis

Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: An implication for the pathogenesis of arthritis

(2009) Sang-Heng Kok et al.   ARTHRITIS AND RHEUMATISM

A critical role of Cyr61 in interleukin-17–dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis

(2009) Qiuyu Zhang et al.   ARTHRITIS AND RHEUMATISM

Silencing cAMP-response Element-binding Protein (CREB) IdentifiesCYR61as a Tumor Suppressor Gene in Melanoma

(2009) Andrey S. Dobroff et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Simvastatin as a Novel Strategy To Alleviate Periapical Lesions

(2009) Sze-Kwan Lin et al.   JOURNAL OF ENDODONTICS

Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: A potential therapeutic benefit for arthritis

(2008) Sze-Kwan Lin et al.   ARTHRITIS AND RHEUMATISM

Evidence that cytokines play a role in rheumatoid arthritis

(2008) Fionula M. Brennan et al.   JOURNAL OF CLINICAL INVESTIGATION

Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation

(2008) Y. Akasaki et al.   OSTEOARTHRITIS AND CARTILAGE